Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2007 2
2008 1
2010 1
2011 1
2013 1
2014 1
2017 2
2018 1
2019 1
2020 1
2021 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors.
Araujo-Fernandez I, Delgado J, Moscetti L, Sarac SB, Zander H, Mueller-Egert S, Dunder K, Pean E, Bergmann L, Enzmann H, Pignatti F. Araujo-Fernandez I, et al. Among authors: dunder k. ESMO Open. 2021 Feb;6(1):100008. doi: 10.1016/j.esmoop.2020.100008. Epub 2020 Dec 16. ESMO Open. 2021. PMID: 33399074 Free PMC article. Review.
Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases.
Stefanska AM, Distlerová D, Musaus J, Olski TM, Dunder K, Salmonson T, Mentzer D, Müller-Berghaus J, Hemmings R, Veselý R. Stefanska AM, et al. Among authors: dunder k. Arch Dis Child. 2017 Oct;102(10):952-957. doi: 10.1136/archdischild-2016-312259. Epub 2017 May 29. Arch Dis Child. 2017. PMID: 28554892 Review.
Pancreatic safety of incretin-based drugs--FDA and EMA assessment.
Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, Rosebraugh C. Egan AG, et al. Among authors: dunder k. N Engl J Med. 2014 Feb 27;370(9):794-7. doi: 10.1056/NEJMp1314078. N Engl J Med. 2014. PMID: 24571751 Free article. No abstract available.
Rosiglitazone: a European regulatory perspective.
Blind E, Dunder K, de Graeff PA, Abadie E. Blind E, et al. Among authors: dunder k. Diabetologia. 2011 Feb;54(2):213-8. doi: 10.1007/s00125-010-1992-5. Epub 2010 Dec 14. Diabetologia. 2011. PMID: 21153629 No abstract available.
16 results